webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Bis-PEG6-NHS ester

  CAS No.: 1526718-98-8   Cat No.: BADC-00960   Purity: ≥95% 4.5  

Bis-PEG6-NHS ester is a non-cleavable 6-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs).

Bis-PEG6-NHS ester

Structure of 1526718-98-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C24H36N2O14
Molecular Weight
576.55
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
NHS-PEG6-NHS; 4,7,10,13,16,19-Hexaoxadocosanedioic acid, 1,22-bis(2,5-dioxo-1-pyrrolidinyl) ester; Bis(2,5-dioxopyrrolidin-1-yl) 4,7,10,13,16,19-hexaoxadocosanedioate; Di-NHS Ester-PEG6; 1,1'-[(1,22-Dioxo-4,7,10,13,16,19-hexaoxadocosane-1,22-diyl)bis(oxy)]di(2,5-pyrrolidinedione); 2,5-Pyrrolidinedione, 1,1'-[(1,22-dioxo-4,7,10,13,16,19-hexaoxadocosane-1,22-diyl)bis(oxy)]bis-
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
InChI
InChI=1S/C24H36N2O14/c27-19-1-2-20(28)25(19)39-23(31)5-7-33-9-11-35-13-15-37-17-18-38-16-14-36-12-10-34-8-6-24(32)40-26-21(29)3-4-22(26)30/h1-18H2
InChIKey
FDLGRFGWAMAWTE-UHFFFAOYSA-N
Density
1.4±0.1 g/cm3
Solubility
Soluble in DCM, DMSO
Flash Point
352.6±34.3 °C
Index Of Refraction
1.529
Vapor Pressure
0.0±2.0 mmHg at 25°C
Appearance
Pale Yellow or Colorless Oily Matter
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at 2-8°C
Boiling Point
659.4±65.0°C at 760 mmHg
Biological Activity
Bis-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

Bis-PEG6-NHS ester, a versatile bifunctional reagent, finds extensive use in bioconjugation and drug delivery applications owing to its unique ability to connect biomolecules. Here are four key applications of Bis-PEG6-NHS ester delivered with a high degree of perplexity and burstiness:

Drug Delivery Systems: Positioned at the forefront of drug delivery innovation, Bis-PEG6-NHS ester plays a pivotal role in crafting drug delivery systems. It acts as a crucial bridge linking therapeutic agents to carrier molecules like nanoparticles or proteins, thereby enhancing drug solubility, stability, and bioavailability. This enables targeted and sustained release of therapeutics, ultimately elevating treatment efficacy while mitigating undesirable side effects.

Protein Crosslinking: Within the realm of protein chemistry, Bis-PEG6-NHS ester serves as a cornerstone for crosslinking proteins, facilitating the exploration of intricate protein-protein interactions and the stabilization of protein complexes. By establishing robust covalent bonds between amino groups of lysine residues on diverse proteins, researchers delve into the structural and functional dimensions of complex biological systems, shedding light on fundamental cellular processes and protein functionality.

Immunoassays Development: In the arena of immunoassays development, Bis-PEG6-NHS ester emerges as a valuable asset employed to conjugate antibodies to detection enzymes or fluorophores. This strategic coupling enhances the sensitivity and specificity of diagnostic assays, crucial for both diagnostics and research. Improved signal detection mechanisms enable precise quantification of biomarkers and analytes in a myriad of samples, catapulting the accuracy of immunoassay outcomes to new heights.

Surface Functionalization: Embarking on a journey into biomaterial science, Bis-PEG6-NHS ester takes center stage in surface functionalization processes aimed at enhancing medical devices and biosensors. By tethering bioactive molecules to these surfaces, it elevates the biocompatibility and functionality of implants, diagnostic tools, and tissue engineering scaffolds. This pivotal role contributes to enhanced patient outcomes and propels advancements in medical device technology to newer horizons.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: ALPHA-AMANITIN | Mal-C6-α-Amanitin | ε-Amanitin | 5-Maleimidovalericacid-NHS | Dideoxy-amanitin | Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA | Acid-PEG1-bis-PEG3-BCN | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester | Fmoc-NH-ethyl-SS-propionic NHS ester | Fmoc-NH-PEG2-NH2 | Bis-PEG6-NHS ester
Send Inquiry
Verification code
Inquiry Basket